CVS Subsidiary Omnicare Hires Alvarez & Marsal for Consulting Services
PorAinvest
jueves, 11 de septiembre de 2025, 1:05 pm ET1 min de lectura
CVS--
The decision to hire Alvarez & Marsal follows a significant legal setback for Omnicare and its parent company, CVS Health. A federal judge recently denied their motion to overturn a drug-fraud suit, ordering Omnicare to pay $406.8 million in treble damages and $542 million in statutory penalties. CVS Health is liable for $164.8 million of these penalties [1].
The consulting firm will work with Omnicare to develop a plan to improve its performance and stabilize its operations. The company has faced increased operating expenses, with costs rising by $859 million, or 8.9% on a year-over-year basis for the six months that ended June 30, 2025 [2].
This latest development underscores the ongoing challenges faced by Omnicare and the broader healthcare industry. As the company seeks to navigate these difficulties, investors and stakeholders will be closely monitoring the progress made by Alvarez & Marsal and the strategies implemented to turn around Omnicare's performance.
Omnicare, a CVS Health subsidiary, has hired consulting firm Alvarez & Marsal to help stabilize the company. Omnicare provides pharmacy services to long-term care and post-acute facilities, as well as assisted living communities. The move comes as the company faces challenges in the industry. The consulting firm will help Omnicare address operational and financial issues, and develop a plan to improve its performance.
Omnicare, a subsidiary of CVS Health, has engaged consulting firm Alvarez & Marsal to address operational and financial issues, according to recent reports. The move comes amidst growing challenges within the industry, particularly for Omnicare, which provides pharmacy services to long-term care and post-acute facilities, as well as assisted living communities.The decision to hire Alvarez & Marsal follows a significant legal setback for Omnicare and its parent company, CVS Health. A federal judge recently denied their motion to overturn a drug-fraud suit, ordering Omnicare to pay $406.8 million in treble damages and $542 million in statutory penalties. CVS Health is liable for $164.8 million of these penalties [1].
The consulting firm will work with Omnicare to develop a plan to improve its performance and stabilize its operations. The company has faced increased operating expenses, with costs rising by $859 million, or 8.9% on a year-over-year basis for the six months that ended June 30, 2025 [2].
This latest development underscores the ongoing challenges faced by Omnicare and the broader healthcare industry. As the company seeks to navigate these difficulties, investors and stakeholders will be closely monitoring the progress made by Alvarez & Marsal and the strategies implemented to turn around Omnicare's performance.

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios